Literature DB >> 18394450

Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions.

Nancy K Sweitzer1, Margarita Lopatin, Clyde W Yancy, Roger M Mills, Lynne W Stevenson.   

Abstract

Heart failure (HF) with normal ejection fraction (EF) is an increasingly common presentation of acute decompensated HF. Differences between patients with HF and truly normal EF and those with mildly impaired EF have not been described. The Acute Decompensated Heart Failure Registry (ADHERE) contains information on >100,000 HF hospitalizations and may provide insight into this distinction. The ADHERE database was used to investigate differences between patients hospitalized with HF and severely (<25%), moderately (25% to 40%), and mildly (40% to 55%) decreased EF and those with normal EF (> or =55%). The group with normal EF was 69% women with a mean age of 74 years (p <0.0001 vs all other groups). Coronary artery disease was less frequent in the normal EF group, and hypertension played a larger role. Patients with EF > or =55% had increased pulse pressure, suggesting a role for arterial stiffening. Treatment differed by EF. Creatinine increased > or =0.5 mg/dl more often in the group with HF and normal EF than in the group with HF and severely decreased EF. In-hospital mortality and length of stay in the intensive care unit varied inversely with EF; overall length of stay was similar. In conclusion, patients with HF and normal EF are more likely to be women, have a history of high pulse pressure hypertension, less coronary artery disease, and a lower risk of inpatient death but a higher likelihood of deterioration in renal function during hospitalization. These observations may be important considerations in the design of future clinical trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394450      PMCID: PMC2390999          DOI: 10.1016/j.amjcard.2007.12.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.

Authors:  Dalane W Kitzman; William C Little; Peter H Brubaker; Roger T Anderson; W Gregory Hundley; Christian T Marburger; Bridget Brosnihan; Timothy M Morgan; Kathryn P Stewart
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

2.  Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest.

Authors:  Michaela Kozakova; Alan G Fraser; Simona Buralli; Armando Magagna; Antonio Salvetti; Ele Ferrannini; Carlo Palombo
Journal:  Hypertension       Date:  2005-02-21       Impact factor: 10.190

3.  ACE inhibition in acute myocardial infarction.

Authors:  M A Pfeffer
Journal:  N Engl J Med       Date:  1995-01-12       Impact factor: 91.245

4.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

5.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

6.  Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.

Authors:  Marc Klapholz; Matthew Maurer; April M Lowe; Frank Messineo; Jay S Meisner; Judith Mitchell; Jill Kalman; Robert A Phillips; Richard Steingart; Edward J Brown; Robert Berkowitz; Robert Moskowitz; Anita Soni; Donna Mancini; Rachel Bijou; Khashayar Sehhat; Nikita Varshneya; Marrick Kukin; Stuart D Katz; Lynn A Sleeper; Thierry H Le Jemtel
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

7.  Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness.

Authors:  C M Viscoli; R I Horwitz; B H Singer
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

8.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.

Authors:  Michael R Zile; Catalin F Baicu; William H Gaasch
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

9.  Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

10.  Increases in central aortic impedance precede alterations in arterial stiffness measures in type 1 diabetes.

Authors:  Nancy K Sweitzer; Mohan Shenoy; James H Stein; Sunduz Keles; Mari Palta; Tamara LeCaire; Gary F Mitchell
Journal:  Diabetes Care       Date:  2007-08-08       Impact factor: 19.112

View more
  47 in total

1.  Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia.

Authors:  Bassel Noumi; Sergio Teruya; Say Salomon; Stephen Helmke; Mathew S Maurer
Journal:  Congest Heart Fail       Date:  2011-01-24

2.  Congestion is the driving force behind heart failure.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2012-09

Review 3.  Prognostic factors in patients hospitalized for heart failure.

Authors:  Lakshmi Sridharan; Liviu Klein
Journal:  Curr Heart Fail Rep       Date:  2013-12

4.  Hospital variation in noninvasive positive pressure ventilation for acute decompensated heart failure.

Authors:  Vivek T Kulkarni; Nancy Kim; Ying Dai; Kumar Dharmarajan; Kyan C Safavi; Behnood Bikdeli; Peter K Lindenauer; Jeffrey Testani; Daniel L Dries; Harlan M Krumholz
Journal:  Circ Heart Fail       Date:  2014-03-14       Impact factor: 8.790

Review 5.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

Review 6.  Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.

Authors:  Annamaria Iorio; Andrea Pozzi; Michele Senni
Journal:  Curr Heart Fail Rep       Date:  2017-06

7.  Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction.

Authors:  Alison Brann; Satit Janvanishstaporn; Barry Greenberg
Journal:  JAMA Cardiol       Date:  2020-09-01       Impact factor: 14.676

8.  Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings.

Authors:  Andrew H Coles; Kimberly Fisher; Chad Darling; Jorge Yarzebski; David D McManus; Joel M Gore; Darleen Lessard; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2014-07-02       Impact factor: 2.778

Review 9.  Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists.

Authors:  Giorgio Graziani; Daniela Pini; Silvia Oldani; David Cucchiari; Manuel Alfredo Podestà; Salvatore Badalamenti
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

10.  Theodore E. Woodward Award: Coming in out of the rain. Relieving congestion in heart failure.

Authors:  Lynne Warner Stevenson
Journal:  Trans Am Clin Climatol Assoc       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.